Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Venous Therapies

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to acquire Veniti Inc., which has ...

Home August 08, 2018
Home
Videos | Stents Bioresorbable

Patrick Serruys, M.D., Ph.D., Imperial College London, explains where development of bioresorbable scaffolds stands in ...

Home August 06, 2018
Home
News | Blood Testing

August 6, 2018 — A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency ...

Home August 06, 2018
Home
News | Embolic Protection Devices

August 3, 2018 — Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a ...

Home August 03, 2018
Home
CT-FFR example showing heavily calcified coronary arteries on CT that did not have hemodynamically significant impact on blood flow.
Feature | Dave Fornell, Editor

August 2, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home August 02, 2018
Home
News | Stents Carotid

July 30, 2018 — Silk Road Medical Inc. recently announced the presentation of real-world data for the treatment of ...

Home July 30, 2018
Home
The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system  is being tested in the SUMMIT Trial.
Feature | Heart Valve Technology

July 26, 2018 — The pivotal clinical study in the U.S. of the Abbott Tendyne Transcatheter Mitral Valve Replacement ...

Home July 26, 2018
Home
News | FFR Technologies

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus ...

Home July 26, 2018
Home
A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.
Feature | CT Angiography (CTA) | Dave Fornell, Editor

The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of ...

Home July 23, 2018
Home
News | Embolic Protection Devices

July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has ...

Home July 20, 2018
Home
Videos | CT Angiography (CTA)

Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine ...

Home July 19, 2018
Home
News | Atherectomy Devices

July 18, 2018 — Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for pe ...

Home July 18, 2018
Home
Technology | Heart Valve Technology

July 18, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next ...

Home July 18, 2018
Home
Videos | Heart Valve Technology

Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver ...

Home July 18, 2018
Home
Videos | Computed Tomography (CT)

An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Trial ...

Home July 17, 2018
Home
Subscribe Now